Tandem Diabetes Care to Sponsor No. 24 Chevrolet Silverado
STATESVILLE, N.C. (May 5, 2021) – GMS Racing officials announced today that Ryan Reed will pilot the No. 24 Tandem Diabetes Care Chevrolet Silverado at Darlington Raceway this Friday.
“I’m so excited and I can’t thank Chevy and everyone at GMS, Mike (Beam) and Maury (Gallagher), enough for the opportunity,” said Reed. “It is awesome to see a new partner come into the sport with Tandem Diabetes Care. I use their t:slim X2 insulin pump to help manage my type 1 diabetes and their advanced Control-IQ technology has improved my health overall. It’s incredible to be able to represent them on the track and have my daily life changed by their product.”
A new partner in NASCAR, Tandem Diabetes Care is dedicated to making the lives of people with diabetes better through relentless innovation and revolutionary customer experience.
“We are thrilled that Ryan (Reed) is experience the benefits of the t:slim X2 pump with Control-IQ technology, and couldn’t be more excited to support him in following his passion,” said John Sheridan, President and CEO, Tandem Diabetes Care. “We’re constantly hearing from customers about how our technology is changing lives and we believe that Ryan getting behind the wheel this weekend is yet another example of these positive outcomes.”
“We’re very grateful to have talented drivers like Ryan (Reed) to be able to step up and compete for us,” said Mike Beam, President of GMS Racing. “We’re thankful for him and his partner Tandem Diabetes Care for coming on board with us for Darlington.”
The No. 24 Tandem Diabetes Care Chevrolet Silverado will make it’s on-track debut in the LIftKits4Less.com 200 at Darlington Raceway on Friday, May 7. The race will be broadcast live on FS1 and MRN.
About GMS Racing – GMS Racing competes full-time in the NASCAR Camping World Truck Series with drivers Sheldon Creed, Zane Smith, Tyler Ankrum and Chase Purdy. The team also competes in the ARCA Racing Series with Jack Wood. Since the team began in 2014, gas Racing won the 2016 and 2020 Camping World Trucks Championship, the 2015 ARCA Racing Series championship as well as the 2019 & 2020 ARCA East championship and 2020 Sioux Chief Showdown championship. GMS has grown to occupy several buildings located in Statesville, N.C. The campus also includes operations for GMS Fabrication. More information can be found at https:/gmsracing.net.
About Tandem Diabetes Care – Tandem Diabetes Care, Inc. (https://www.tandemdiabetes.com/) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. The t:slim X2 pump is capable of remote feature updates using a personal computer. Tandem is based in San Diego, California.
Responsible use of Control-IQ Technology
Even with advanced systems such as the t:slim X2 insulin pump with Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Since there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.
Important Safety Information:
RX ONLY.
Indications for Use:
t:slim X2 insulin pump
The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use with NovoLog or Humalog U-100 insulin.
Control-IQ technology
Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Contraindications and Warnings:
WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea.
Users of the t:slim X2 pump and Control-IQ technology must:
- be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use;
- test blood glucose levels as recommended by their healthcare provider;
- demonstrate adequate carb-counting skills;
- maintain sufficient diabetes self-care skills;
- see healthcare provider(s) regularly; and
- have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders;
- The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
Tandem Diabetes Care, Inc., t:slim X2 and Control-IQ are trademarks of Tandem Diabetes Care, Inc.
